OP Asset Management Ltd bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 46,309 shares of the company’s stock, valued at approximately $3,296,000.
A number of other hedge funds also recently made changes to their positions in the company. Banque Cantonale Vaudoise boosted its stake in GE HealthCare Technologies by 16,539.1% during the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after buying an additional 25,801 shares during the last quarter. Community Bank of Raymore grew its holdings in GE HealthCare Technologies by 5.4% during the 1st quarter. Community Bank of Raymore now owns 15,795 shares of the company’s stock valued at $1,124,000 after buying an additional 804 shares in the last quarter. Cidel Asset Management Inc. increased its stake in GE HealthCare Technologies by 23.8% in the 1st quarter. Cidel Asset Management Inc. now owns 3,141 shares of the company’s stock worth $224,000 after acquiring an additional 603 shares during the last quarter. Bar Harbor Wealth Management raised its holdings in shares of GE HealthCare Technologies by 7.5% during the 1st quarter. Bar Harbor Wealth Management now owns 25,077 shares of the company’s stock worth $1,785,000 after acquiring an additional 1,753 shares in the last quarter. Finally, SVB Wealth LLC raised its holdings in shares of GE HealthCare Technologies by 13.8% during the 1st quarter. SVB Wealth LLC now owns 8,975 shares of the company’s stock worth $639,000 after acquiring an additional 1,086 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts recently weighed in on GEHC shares. Royal Bank Of Canada started coverage on shares of GE HealthCare Technologies in a report on Tuesday. They issued an “outperform” rating and a $80.00 target price for the company. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lowered their price objective for the company from $75.00 to $69.00 in a research report on Thursday, May 21st. Mizuho dropped their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Argus reduced their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Tuesday, May 19th. Finally, Wells Fargo & Company decreased their target price on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $80.20.
GE HealthCare Technologies Stock Up 1.3%
Shares of NASDAQ:GEHC opened at $65.76 on Friday. The firm has a market capitalization of $29.91 billion, a PE ratio of 15.73, a price-to-earnings-growth ratio of 1.79 and a beta of 0.74. The business has a 50 day simple moving average of $64.51 and a two-hundred day simple moving average of $73.96. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the previous year, the company posted $1.01 earnings per share. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.
Insiders Place Their Bets
In related news, Director Rodney F. Hochman bought 1,618 shares of the stock in a transaction dated Tuesday, May 12th. The stock was purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Peter J. Arduini purchased 4,169 shares of the business’s stock in a transaction dated Thursday, April 30th. The stock was bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders have bought 21,847 shares of company stock valued at $1,361,355. Insiders own 0.36% of the company’s stock.
GE HealthCare Technologies Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
